Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Hemagen Diagnostics Inc. (HMGN) had Revenue of $4.04M for the most recently reported fiscal year, ending 2012-09-30.

Quarterly Annual

Figures for fiscal year ending 2012-09-30

Income Statement Financials
Revenue	$4.04M
Net Income	$-0.91M
Cost of Goods Sold	$2.43M
Gross Profit	$1.61M
Operating Expenses	$4.48M
Operating Income	$-0.44M
Non-Operating Income/Expense	$-0.47M
Pre-Tax Income	$-0.91M
Normalized Pre-Tax Income	$-0.91M
Income after Taxes	$-0.91M
Income from Continuous Operations	$-0.91M
Consolidated Net Income/Loss	$-0.91M
Normalized Income after Taxes	$-0.91M
EBIT	$-0.44M
EBITDA	$-0.27M
Weighted-Average Shares Outstanding (Basic)	15.50M
Weighted-Average Shares Outstanding (Diluted)	15.50M
Earnings per Share (EPS) (Basic)	$-0.06
Earnings per Share (EPS) (Diluted)	$-0.06
Balance Sheet Financials
Current Assets	$2.09M
Property, Plant, and Equipment	$0.28M
Long-Term Assets	$0.35M
Total Assets	$2.44M
Current Liabilities	$1.95M
Long-Term Debt	$4.05M
Long-Term Liabilities	$4.05M
Total Liabilities	$6.00M
Common Equity	$-3.56M
Tangible Shareholders Equity	$-3.56M
Shareholders Equity	$-3.56M
Common Shares Outstanding	15.50M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-0.36M
Cash Flow from Investing Activities	$-0.06M
Cash Flow from Financial Activities	$0.31M
Beginning Cash	$0.21M
End Cash	$0.07M
Increase/Decrease in Cash	$-0.15M
Stock-Based Compensation	$0.05M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.07
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	8.21
Debt to Equity Ratio	-1.41
Gross Margin	39.92%
Operating Margin	-10.83%
EBIT Margin	-10.83%
EBITDA Margin	-6.77%
Pre-Tax Profit Margin	-22.45%
Profit Margin	-22.45%
Free Cash Flow	$-0.45M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.65
Inventory Turnover	1.78
Receiveable Turnover	6.88
Days Sales in Receivables	53.05
Return on Equity	25.51%
Return on Tangible Equity	25.51%
Return on Assets	-37.14%
Return on Investments	-184.02%
Book Value Per Share	$-0.23
Free Cash Flow per Share	$-0.03
Operating Cash Flow per Share	$-0.02

Data from Zacks Investment Research, Inc.